TabMenu
] Filters: Author is Ballreich, J. [Clear All Filters]
. Reducing branded prescription drug prices: A review of policy options. Pharmacotherapy. 2017. Abstract
. Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry. Appl Health Econ Health Policy. 2018;16:753-763. Abstract
. Bridging the Silos of Service Delivery for High-Need, High-Cost Individuals. Popul Health Manag. 2016;19:421-428. Abstract
. Branded prescription drug spending: a framework to evaluate policy options. J Pharm Policy Pract. 2017;10:31. Abstract
. Attributes common to programs that successfully treat high-need, high-cost individuals. Am J Manag Care. 2015;21:e597-600. Abstract